OR2M1P

Across TCGA pan-cancer cohorts, OR2M1P Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated OR2M1P data layer compared with 11 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher OR2M1P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated OR2M1P expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

HNSC, LGG, and UCEC are the cancer types where OR2M1P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.156	0.710	.002	24	view →
LGG	OS	Median	All	0.182	0.909	<.001	12	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
SKCM	OS	Median	II,III,IV	1.000	0.725	.037	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

OR2M1P–HNSC (OS)

Open the HNSC breakdown →